Back to Research Hub
Novartis AG
NVS
$149.12+2.70 (+1.84%)
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers.
StreetsValue research for Novartis AG (NVS)
Members get the full report for Novartis AG: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.